The limits of simulation of the clotting system

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 6, 2006, Pages 1331-1338

  Wagenvoord, R ^a   Hemker, P W ^b   Hemker, H C ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b CWI   (Netherlands)

Author keywords

Mathematical simulation; Model discrimination; Thrombin generation

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 5A; BLOOD CLOTTING FACTOR 8; PROTHROMBIN; THROMBIN;

ACCURACY; ARTICLE; BIOCHEMISTRY; BLOOD CLOTTING; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; HEMATOLOGICAL PARAMETERS; HEMOPHILIA A; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; MEDICAL INFORMATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIMULATION; VALIDATION STUDY;

BLOOD COAGULATION; COMPUTER SIMULATION; FACTOR V; FACTOR VIII; FACTOR X; HEMOPHILIA A; HUMANS; MODELS, BIOLOGICAL; PROTEIN C; PROTHROMBIN; THROMBIN; THROMBOMODULIN;

EID: 33646776757     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.01967.x     Document Type: Article

References (43)

1. Biggs R, Macfarlane RG. Human Blood Coagulation and its Disorders. Oxford: Blackwell, 1953.
2. Hemker HC, Beguin S. Phenotyping the clotting system. Thromb Haemost 2000; 84: 747-51.
3. Baglin T. The measurement and application of thrombin generation. Br J Haematol 2005; 130: 653-61.
4. Willems GM, Lindhout T, Hermens WT, Hemker HC. Simulation model for thrombin generation in plasma. Haemostasis 1991; 21: 197-207.
5. Jones KC, Mann KG. A model for the tissue factor pathway to thrombin. II. A mathematical simulation. J Biol Chem 1994; 269: 23367-73.
6. Hemker PW. Numerical methods for differential equations in system simulation and in parameter estimation. In: Hemker HC, Hess B, eds. Analysis and Simulation of Biochemical Systems. North Holland: Elsevier, 1972: 59-80.
7. Cornish-Bowden A. Fundamentals of Enzyme Kinetics. London: Portland Press, 2004.
8. Adams TE, Everse SJ, Mann KG. Predicting the pharmacology of thrombin inhibitors. J Thromb Haemost 2003; 1: 1024-7.
9. Brummel-Ziedins K, Vossen CY, Rosendaal FR, Umezaki K, Mann KG. The plasma hemostatic proteome: Thrombin generation in healthy individuals. J Thromb Haemost 2005; 3: 1472-81.
10. Brummel-Ziedins KE, Pouliot RL, Mann KG. Thrombin generation: Phenotypic quantitation. J Thromb Haemost 2004; 2: 281-8.
11. Bungay SD, Gentry PA, Gentry RD. A mathematical model of lipid-mediated thrombin generation. Math Med Biol 2003; 20: 105-29.
12. Butenas S, Orfeo T, Gissel MT, Brummel KE, Mann KG. The significance of circulating factor IXa in blood. J Biol Chem 2004; 279: 22875-82.
13. Chandler WL, Velan T. Estimating the rate of thrombin and fibrin generation in vivo during cardiopulmonary bypass. Blood 2003; 101: 4355-62.
14. Hockin MF, Jones KC, Everse SJ, Mann KG. A model for the stoichiometric regulation of blood coagulation. J Biol Chem 2002; 277: 18322-33.
15. Nagashima H. Studies on the different modes of action of the anticoagulant protease inhibitors DX-9065a and Argatroban. I. Effects on thrombin generation. J Biol Chem 2002; 277: 50439-44.
16. Obraztsov IF, Kuz'min VM, Khanin MA, Kogan AE, Anan'eva NM, Saenko EL. Effect of factor VIII deficiency on generation of thrombin: A biomechanical approach. Dokl Biochem Biophys 2002; 383: 119-21.
17. Qiao YH, Liu JL, Zeng YJ. A kinetic model for simulation of blood coagulation and inhibition in the intrinsic path. J Med Eng Technol 2005; 29: 70-4.
18. Tyurin KV, Khanin MA. Optimality principle and determination of kinetic constants for biochemical reactions. Math Med Biol 2005; 22: 1-14.
19. Beguin S, Lindhout T, Hemker HC. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin. Thromb Haemost 1989; 61: 25-9.
20. Rosing J, Tans G, Govers-Riemslag JW, Zwaal RF, Hemker HC. The role of phospholipids and factor Va in the prothrombinase complex. J Biol Chem 1980; 255: 274-83.
21. Regnault V, Rivat C, Pfister M, Stoltz JF. Monoclonal antibodies against human plasma protein C and their uses for immunoaffinity chromatography. Thromb Res 1991; 63: 629-40.
22. Hemker HC, Giesen P, Al Dieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S. The calibrated automated thrombogram (CAT): A universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32: 249-53.
23. Anderson TW. Introduction to Multivariate Statistical Analysis. New York: John Wiley, 1958.
24. Golub GH, Ortega JM. Scientific Computing and Differential Equations: An Introduction to Numerical Methods. Orlando, FL, USA: Academic Press, Inc., 1962.
25. Walter E, Pronzato C. Identification of Parametric Models from Experimental Data. London: Springer, 1997.
26. Al Dieri R, Peyvandi F, Santagostino E, Giansily M, Mannucci PM, Schved JF, Beguin S, Hemker HC. The thrombogram in rare inherited coagulation disorders: Its relation to clinical bleeding. Thromb Haemost 2002; 88: 576-82.
27. van Dijk K, van der Bom JG, Lenting PJ, de Groot PG, Mauser-Bunschoten EP, Roosendaal G, Grobbee DE, van den Berg HM. Factor VIII half-life and clinical phenotype of severe hemophilia A. Haematologica 2005; 90: 494-8.
28. Butenas S, Branda RF, van't Veer C, Cawthern KM, Mann KG. Platelets and phospholipids in tissue factor-initiated thrombin generation. Thromb Haemost 2001; 86: 660-7.
29. Beguin S, Kessels H, Dol F, Hemker HC. The consumption of antithrombin III during coagulation, its consequences for the calculation of prothrombinase activity and the standardisation of heparin activity. Thromb Haemost 1992; 68: 136-42.
30. Billy D, Willems GM, Hemker HC, Lindhout T. Prothrombin contributes to the assembly of the factor Va-factor Xa complex at phosphatidylserine-containing phospholipid membranes. J Biol Chem 1995; 270: 26883-9.
31. Govers-Riemslag JW, Janssen MP, Zwaal RF, Rosing J. Effect of membrane fluidity and fatty acid composition on the prothrombin-converting activity of phospholipid vesicles. Biochemistry 1992; 31: 10000-8.
32. Smeets EF, Comfurius P, Bevers EM, Zwaal RF. Contribution of different phospholipid classes to the prothrombin converting capacity of sonicated lipid vesicles. Thromb Res 1996; 81: 419-26.
33. Broze Jr GJ. Protein Z-dependent regulation of coagulation. Thromb Haemost 2001; 86: 8-13.
34. Heeb MJ, Mesters RM, Tans G, Rosing J, Griffin JH. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem 1993; 268: 2872-7.
35. Arnout J, Vermylen J. Mechanism of action of beta2-glycoprotein I-dependent lupus anticoagulants. Lupus 1998; 7: S23-8.
36. Masuda J, Takayama E, Satoh A, Ida M, Shinohara T, Kojima-Aikawa K, Ohsuzu F, Nakanishi K, Kuroda K, Murakami M, Suzuki K, Matsumoto I. Levels of annexin IV and V in the plasma of pregnant and postpartum women. Thromb Haemost 2004; 91: 1129-36.
37. Rand JH. The pathogenic role of annexin-V in the antiphospholipid syndrome. Curr Rheumatol Rep 2000; 2: 246-51.
38. Anderson NL, Polanski M, Pieper R, Gatlin T, Tirumalai RS, Conrads TP, Veenstra TD, Adkins JN, Pounds JG, Fagan R, Lobley A. The human plasma proteome: A nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 2004; 3: 311-26.
39. Hemker HC, DeSmedt E, Hemker PW. During coagulation thrombin generation shifts from chemical to diffusional control. J Thromb Haemost 2005; 3: 2399-400.
40. Hemker HC, Al Dieri R, Beguin S. Thrombin generation assays: Accruing clinical relevance. Curr Opin Hematol 2004; 11: 170-5.
41. Popper KR. Conjectures and Refutations: The growth of scientific knowledge. New York: Harper Torchbooks, 1963.
42. Stortelder WJH. Parameter estimation in nonlinear dynamical systems. PhD Thesis. the Netherlands: CWI-Amsterdam, 1998: 1-174.
43. Everaars CTH, Hemker PW, Stortelder WJH. Manual of spIds, A Software Package for Parameter Identification in Dynamic Systems. CWI Report NM-R9521. Amsterdam: Centrum voor Wiskunde en Informatica, 1995.